Care pathway for anaphylaxis
The College's care pathway for anaphylaxis is presented in two parts:
- an algorithm with the stages of ideal care, and
- a set of competences required to diagnose, treat and optimally manage anaphylaxis.
The algorithm has numbers which correspond to the competences outlined within the body of the document. Download the full anaphylaxis pathway:(PDF, 506KB, 11 pages).
We recommend that this pathway is implemented locally by a multidisciplinary team with a focus on creating networks between staff in primary and community health care, social care, education and hospital-based practice to improve services for children with allergic conditions. All specialists should have paediatric training.
Anaphylaxis is a severe, life-threatening, generalised or systemic hypersensitivity reaction which is likely when both of the following criteria are met:
- sudden onset and rapid progression of symptoms
- life-threatening airway and/or breathing and/or circulation problems
Skin and/or mucosal changes (flushing, urticaria, angio-oedema) can also occur, but are absent in a significant proportion of cases.
The Anaphylaxis Working Group (AWG) identified four key recommendations from the evidence base, these are:
- prompt administration of adrenaline by intramuscular injection is the cornerstone of therapy both in the hospital and in the community
- children and young people at risk of anaphylaxis should be referred to clinics with specialist competence in paediatric allergies
- risk analysis should be performed for all patients with suspected anaphylaxis
- provision of a management plan may reduce the frequency and severity of further reactions and is a recommended part of anaphylaxis management
Additionally, we recommend that all deaths from suspected anaphylaxis should be recorded on a local register. We strongly support the creation of a National Anaphylaxis Register.
Core knowledge documents
The core knowledge documents comprise the clinical guidance which informed the development of the care pathway. Healthcare professionals diagnosing and managing children with anaphylaxis should be aware of the following clinical guidance:
- The Resuscitation Council UK (Resus UK) guideline on the emergency medical treatment of anaphylactic reactions
- The European Academy of Allergy and Clinical Immunology (EAACI) guideline on the management of anaphylaxis in childhood (PDF, 655KB, 15 pages)
- The Guidelines in Emergency Medicine Network (GEMNet) guideline for the management of acute allergic reactions (PDF, 216KB, 32 pages)
Associated Publications, Resources and Links
- Stakeholder organisations
The following organisations have registered as project stakeholders or are partners in the National Epilepsy Audit: ...
- Four Children's Commissioners unite to protect children's rights
March 2011: RCPCH Policy Event: 'Four Children's Commissioners unite to protect children's rights' All ...
- British National Formulary for Children (BNFC)
British National Formulary for Children (BNFC) provides up to date information on using medicines to treat ...
- Chairman's Welcome
Dear Colleagues, Welcome. As chair of the Academic Board, I have the privilege and ...
- RCPCH International
'Working with partners in the UK and overseas to advance global child health' News ...
- Frequently asked questions
Here are some frequently asked questions on each of our examinations. Please refer to them for up-to-date information ...